Skip to main content
. 2020 Jan 9;15(7):1266–1273. doi: 10.4103/1673-5374.272616

Figure 4.

Figure 4

Full analysis set (FAS) analysis of the degree of recovery using the National Institutes of Health Stroke Scale scores of acute cerebral infarction patients in the cattle encephalon glycoside and ignotin (CEGI) group and the placebo group on days 14 (A) and 90 (B) after treatment.

The rank-sum test was used for comparison. The FAS consisted of 229 and 78 cases in the CEGI and placebo groups, respectively.